2013 November

 

2013  Sept-Oct

Agnieszka Balkowiec-11. Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats.  J Neurosci Res. 2013 Feb;91(2):220-9.


3. Derivation of a mathematical expression for predicting the time to cardiac events in patients with heart failure: a retrospective clinical study. Hypertens Res. 2013 May;36(5):450-6.

5. Aortic stiffness and vitamin D are independent markers of aortic calcification in patients with peripheral arterial disease and in healthy subjects. Eur J Vasc Endovasc Surg. 2011 Nov;42(5):689-95.

7. Diesel exhaust induced pulmonary and cardiovascular impairment: the role of hypertension intervention. Toxicol Appl Pharmacol. 2013 Apr 15;268(2):232-40.

10. Rate and Predictors of Blood Pressure Control in a Federal Qualified Health Center in Michigan: A Huge Concern? Journal of Clinical Hypertension. 2013 Apr; 15(4):254-63.

12. Blood pressure and Purdue pegboard scores in individuals with hypertension after alternate nostril breathing, breath awareness, and no intervention. Med Sci Monit. 2013 Jan 21;19:61-6.

Van Anthony M. Villar-314. Novel role of sorting nexin 5 in renal D(1) dopamine receptor trafficking and function: implications for hypertension. FASEB J. 2013 May;27(5):1808-19.



15. Serum placental growth factor as a predictor of early onset preeclampsia in overweight/obese pregnant women. J Am Soc Hypertens. 2013 Mar-Apr;7(2):137-48.


Sharlene Lopes Pereira-117. A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension. Eur J Pharmacol.2013 Feb;702(1-3):316-322.


19. The relationship between insomnia symptoms and hypertension using United States population-level data. J Hypertens. 2013 Apr;31(4):663-71.

21. Effects of CPAP on systemic hypertension in OSAH: a monocentric, observational, cohort study. Respir Med. 2012 Sep;106(9):1329-34.

EJVES (Figure 1)2. Structural and biochemical characteristics of arterial stiffness in patients with atherosclerosis and in healthy subjects.  Hypertens Res. 2012 Oct;35(10):1032-7.


4. Correlation between Left Ventricular Mass Index and Calcium Metabolism in Patients with Essential Hypertension. Balk Med J.2013 Mar;30(1):85-89.

6. Basal and postprandial serum levels of gastrin in normotensive and hypertensive adults. Clin Exp Hypertens. 2013;35(1):74-8.

8. Establishment of the ocular hypertension model using the common marmoset. Exp Eye Res. 2013 Jun;111:1-8.

Geofrey Musinguzi-19. Prevalence, awareness and control of hypertension in Uganda. PLoS One. 2013 Apr 17;8(4):e62236






11. Successful treatment of pulmonary hypertension with beraprost and sildenafil after cord blood transplantation for infantile leukemia. Int J Hematol. 2013 Jan;97(1):147-50.

Dra Quintana Villamandos16. Early regression of left ventricular hypertrophy after treatment with esmolol in an experimental rat model of primary hypertension. Hypertens Res. 2013 May;36(5):408-13

Gisele Zapata Sudo-218. Vasodilatory activity and antihypertensive profile mediated by inhibition of phosphodiesterase type 1 induced by a novel sulfonamide compound. Fundamental & Clinical Pharmacology 26 (2012) 690–700.


20. 24-h ambulatory recording of aortic pulse wave velocity and central systolic augmentation: a feasibility study. Hypertens Res. 2012 Oct;35(10):980-7.

22. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension. Pediatr Nephrol. 2013 Jul;28(7):1113-9.

 

Multiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier SchönmannMultiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier Schönmann